Terumo’s OpusWave Dual Sensor Imaging System Introduced in the United States

June 30, 2026—Terumo Interventional Systems, a division of Terumo Corporation, announced the completion of the first United States procedure using its OpusWave dual sensor imaging system. The first United States case introduces the system’s next-generation intravascular imaging capability to support more informed treatment strategies across a broad range of coronary interventions, stated the company.

According to Terumo, the OpusWave imaging system features the DualView imaging catheter, combining optical frequency domain imaging (OFDI) and intravascular ultrasound (IVUS) in a single platform to provide simultaneous, complementary views of the coronary anatomy.

As summarized in the press release, the system is designed to balances deep vessel visualization of IVUS with the high-resolution surface detail of OFDI in a single catheter allowing physicians to assess lesion morphology, plaque composition, and stent deployment with a more comprehensive perspective.

Terumo further noted that the DualView imaging catheter features a 2.6-F profile, 6-F guide compatibility, and advanced hydrophilic coating. It also offers a 150-mm pullback for both IVUS and OFDI. Additionally, its flexible imaging modes—IVUS-only, OFDI-only, or simultaneous dual imaging—allows physicians to tailor imaging to each case while maintaining workflow efficiency.

The initial procedure was performed by Annapoorna S. Kini, MD, at Mount Sinai Fuster Heart Hospital in New York, New York.

“Having both IVUS and OFDI available simultaneously changes how we approach complex cases,” commented Dr. Kini in Terumo’s press release. “Instead of choosing between depth or resolution, we can see both at once—giving us a more complete understanding of the vessel and greater confidence in our decisions.”